Patents by Inventor Bent Winding

Bent Winding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Treatment of a Thoracolumbar Deformity in a Human Subject with Achondroplasia
    Publication number: 20260263563
    Abstract: The present invention relates to methods for the treatment of a spinal deformity, such as thoracolumbar deformity in a subject in need of said treatment, said method comprising the step of administering a therapeutically effective amount of an inhibitor of FGFR3 signaling, or an NPR-B agonist and/or an NPR-C agonist to said subject.
    Type: Application
    Filed: March 19, 2024
    Publication date: September 10, 2026
    Inventors: Bent Winding, Kennett Sprogøe, Mads Jens Kjelgaard-Hansen, Aimee D. Shu, Michael Stuart Ominsky, Leanne Marie Ward, Kevin Mitchell Smit
  • METHOD OF IMPROVING SKELETAL MUSCLE FUNCTION
    Publication number: 20260174751
    Abstract: The present invention relates to methods of improving muscle function in a subject suffering from a disease or condition in which muscle function is impaired, the method comprising administering an effective amount of, an inhibitor of FGFR3 signaling, an NPR-B agonist or an NPR-C agonist to said subject.
    Type: Application
    Filed: November 10, 2023
    Publication date: June 25, 2026
    Inventors: Bent Winding, Kennett Sprogøe, Mads Jens Kjelgaard-Hansen
  • PDAC TREATMENT REGIMEN
    Publication number: 20230085602
    Abstract: The human Interleukin 1 Receptor antagonist anakinra can be used in the treatment of pancreatic ductal adenocarcinoma (PDAC). The treatment involves administration of a daily dose of approximately at least 200 mg of anakinra to a patient in need thereof, for example to a patient who is undergoing a chemotherapy treatment regimen. The anakinra can be used in related treatment methods and corresponding pharmaceutical compositions.
    Type: Application
    Filed: February 4, 2021
    Publication date: March 16, 2023
    Applicant: Swedish Orphan Biovitrum AB (publ )
    Inventors: Bent Winding, Christina Kaiser, Gunilla Huledal